期刊文献+

洛哌丁胺构建大鼠便秘模型对水通道蛋白AQP3和AQP8的影响 被引量:21

Expression of AQP3 and 8 in loperamide induced constipation in rats
下载PDF
导出
摘要 目的:观察洛哌丁胺构建的大鼠便秘模型中水通道蛋白家族中AQP3和AQP8蛋白及其mRNA定量表达,探讨洛哌丁胺构建大鼠便秘模型对AQP3和AQP8的影响.方法:SD♂大鼠30只,随机分为5组,造模开始时处死1组大鼠,检测结肠传输功能及结肠组织的AQP3,8表达水平,作为基准参考线.剩余4组予以洛哌丁胺1.5 mg/(kg·d)灌胃,诱导造模.分别于造模的第3、7天和造模成功后第3、7天各处死一组模型大鼠,检测结肠传输及AQP3,AQP8蛋白及其mRNA定量表达.结果:大鼠粪便含水量在诱导便秘模型的过程中明显减少,停药后7 d,粪便内的水分并不能自发恢复至正常(2.29 g±1.17 g vs 0.80 g±0.27 g,P=0.01<0.05).试验过程中,大鼠结肠传输功能未发生改变(67.72%vs 58.64%,P=0.971>0.05).AQP8远端表达停药7 d上升,与造模7 d时相比,差异有统计学意义(0.43±0.31vs 2.66±0.87,P=0.008).AQP8近端表达给药后迅速上升至较高水平,与正常组对照具有统计学意义(15.96±2.13,P=0.00),停药7 d后其表达再次上升,与给药7 d相比,差异有统计学意义(6.37±0.23 vs 0.79±0.13,P=0.015).停药后,AQP3在结肠近端持续表达下降,与正常对照组相比,差异有统计学意义(0.20±0.06,P=0.04).结论:洛哌丁胺能够提高模型大鼠结肠AQP8表达,促进肠道跨膜水运输,减少粪便含水量而导致便秘. AIM: To observe the differential expression of AQP3 and 8 in loperamide induced constipation in rats, and to explore the role of these two proteins in constipation.METHODS: Thirty male SD rats were randomly divided into five groups. One group was killed at the beginning to measure intestinal transit function and the expression of AQP3 and 8 in human colonic epithelial cells as basic references. Loperamide [1.5 mg/(kg?d)] was given by intragastric administration in the remaining four groups of rats to induce constipation. Two groups of rats were killed on days 3 and 7 after initial loperamide administration, respectively, while the other two groups were killed 3 and 7 d after last loperamide administration, respectively. Intestinal transmission function was determined, and the expression of AQP3 and 8 was detected. RESULTS: Intestinal transit function kept stable(67.72% vs 58.64%, P〈0.05) throughout the experimental process, while fecal water content decreased. The fecal water content could not return to normal 7 d after stopping loperamide(2.29 g ± 1.17 g vs 0.80 g ± 0.27 g, P = 0.01). AQP8 expression in the proximal colon had an upward trend 3 to 7 d after the initial loperamide administration, greatly higher than that in the normal control group(P = 0.00). Seven days after stopping loperamide, AQP8 had a rising trend in both the proximal and distal colons(0.43 ± 0.31 vs 2.66 ± 0.87, P = 0.008), while AQP3 expression declined(6.37 ± 0.23 vs 0.79 ± 0.13, P = 0.015). CONCLUSION: Loperamide enhances the expression of AQP8 in the intestine of rats, which facilitates water movement across the membrane. Deficient water absorption may play a role in the pathogenesis of loperamide induced constipation.
出处 《世界华人消化杂志》 CAS 北大核心 2014年第7期969-974,共6页 World Chinese Journal of Digestology
基金 江苏省六大人才高峰重点课题基金资助项目 No.2011-WS40 国家自然科学基金资助项目 No.81373645 江苏省中医药管理局课题基金资助项目 No.LZ11042~~
关键词 洛哌丁胺 AQP3 AQP8 肠道传输功能 Loperamide AQP3 AQP8 Intestinal transit function
  • 相关文献

参考文献15

  • 1Benga G. Water channel proteins (later called aqua- porins) and relatives: past, present, and future.IUBMB Life 2009; 61:112-133 [PMID: 19165894 DOI: 10.1002/iub.156].
  • 2Awouters F, Niemegeers CJ, Janssen PA. Pharma- cology of antidiarrheal drugs. Annu Rev Pharmacol Toxicol 1983; 23:279-301 [PMID: 6307123 DOI: 10.1146/annurev.pa.23.040183.001431].
  • 3Zavecz JH, Jackson TE, Limp GL, Yellin TO. Rela- tionship between anti-diarrheal activity and bind- ing to calmodulin. Eur J Pharmacol 1982; 78:375-377 [PMID: 6121713].
  • 4Reynolds IJ, Gould RJ, Snyder SH. Loperamide: blockade of calcium channels as a mechanism for antidiarrheal effects. J Pharmacol Exp Ther 1984; 231: 628-632 [PMID: 6502516].
  • 5Zhou M, Jia P, Chen J, Xiu A, Zhao Y, Zhan Y, Chen P, Zhang J. Laxative effects of Salecan on normal and two models of experimental constipated mice. BMC Gastroentero12013; 13:52 [PMID: 23514598 DOh 10.1186/1471-230X-13-52l.
  • 6钱伯初,史红,郑晓亮.正常和便秘模型动物排便实验研究进展[J].中国临床药理学与治疗学,2007,12(12):1339-1343. 被引量:15
  • 7Harries WE, Akhavan D, Miercke LJ, Khademi S, Stroud RM. The channel architecture of aquaporin 0 at a 2.2-A resolution. Proc Natl Acad Sci U S A 2004; 101:14045-14050 [PMID: 15377788 DOI: 10.1073/ pnas.O4052741U1].
  • 8Koyama Y, Yamamoto T, Tani T, Nihei K, Kondo D, Funaki H, Yaoita E, Kawasaki K, Sato N, Hatakeya- ma K, Kihara I. Expression and localization of aquaporins in rat gastrointestinal tract. Am J Physiol 1999; 276:C621-C627 [PMID: 10069989].
  • 9Hardin JA, Wallace LE, Wong JF, O'Loughlin EV,Urbanski SJ, Gall DG, MacNaughton WK, Beck PL. Aquaporin expression is downregulated in a mu- fine model of colitis and in patients with ulcerative colitis, Crohn's disease and infectious colitis. Cell Tissue Res 2004; 318:313-323 [PMID: 15338270 DOI: 10.1007/s00441-004-0932-4].
  • 10Fischer H, Stenling R, Rubio C, Lindblom A. Differen- tial expression of aquaporin 8 in human colonic epi- thelial cells and colorectal tumors. BMC Physio12001; 1: 1 [PMID: 11231887 DOI: 10.1186/1472-6793-1-1].

二级参考文献11

  • 1姚海燕,库宝善,马行,徐英,任彭.中药复方一身清改善便秘小鼠的排便功能[J].中国临床康复,2006,10(19):100-102. 被引量:2
  • 2许东强,余保平,高山,王玮.便秘宁对便秘小鼠排便作用的影响[J].胃肠病学和肝病学杂志,2006,15(3):295-296. 被引量:13
  • 3Tsusumi K, Kishimoto S, Koshitani O, et al. Amitriptyline-induced constipation in cynomolgus monkeys is beneficial for the evaluation of laxative efficacy[J]. Biol Pharm Bull, 2000;23: 657 - 659.
  • 4Sudo H, Ozaki K, Muramatsu H, et al. Mitemcinal (GM-611), an orally active motilin agonist, facilitates defecation in rabbits and dogs without causing loose stools[J]. Neurogastroenterol Motil, 2007;19:318- 326.
  • 5Ito H, Kiso T, Yuki H, et al. Investigation of the effects of YM-31636, a novel 5-HT3 receptor agonist, on defecation in normal and constipated ferrets[ J]. Eur J Pharmacol, 2001; 424:151-157.
  • 6Kobayashi S, Ikeda K, Suzuki M, et al. Effects of YM905, a novel muscarinic M3-receptor antagonist, on experimental models of bowel dysfimction in vivo[J]. Jpn J Pharmacol, 2001;86: 281-288.
  • 7Shimotoyodome A, Meguro S, Hase T, et al. Decreased colonic mucus in rats with loperamide-induced constipation[ J]. Comp Biochem Physiol A Mol Integr Physiol, 2000;126:203-211.
  • 8Shimotoyodome A, Meguro S, Hase T, et al. Sulfated polysaccharides, but not cellulose, increase colonic mucus in rats with loperamide-induced constipation[J]. Dig Dis Sci, 2001; 46: 1482- 1489.
  • 9Ozaki K, Sudo H, Muramatsu H, et al. Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs [ J ]. Inflammophannacology, 2007; 15:36-42.
  • 10Yogo K, Ozaki KI, Takanashi H, et al. Effects of motilin and mitemcinal (GM-611) on gastrointestinal contractile activity in rhesus monkeys in vivo and in vitro[J]. Dig Dis Sci, 2007;52: 3112-3122.

共引文献14

同被引文献271

引证文献21

二级引证文献186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部